Literature DB >> 32435792

Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease.

Erica J Brenner1, Millie D Long1, Courtney M Mann2, Wenli Chen1, Camila Reyes2, Li Lin2, Bryce B Reeve2, Michael D Kappelman1.   

Abstract

BACKGROUND: PROMIS Pediatric domains provide self-reported measures of physical, emotional, and social health in children with chronic conditions. We evaluated the responsiveness of the PROMIS Pediatric measures to changes in disease activity and disease-specific, health-related quality of life (HRQOL) in children with Crohn's disease (CD).
METHODS: IBD Partners Kids & Teens is an internet-based cohort of children with inflammatory bowel disease (IBD). Participants age 9 to 17 report symptoms related to disease activity (short Crohn's Disease Activity Index [sCDAI]), the IMPACT-III HRQOL measure, and 5 PROMIS Pediatric domains. We conducted longitudinal analyses using mixed linear models to examine the extent to which PROMIS Pediatric measures respond to changes in sCDAI and IMPACT-III.
RESULTS: Our study sample included 544 participants with CD (mean age 13 years, 44% female). All PROMIS Pediatric domains responded to changes in sCDAI, indicating improved physical, emotional, and social health, corresponding to improved disease activity and the converse (P < 0.001). Observed effect estimates ranged from 1.8 for peer relationships to 6.8 for fatigue. Of 246 participants with 2 or more completed reports, disease activity was stable in 527, worse in 72, and improved in 67. Changes in PROMIS Pediatric scores were associated with changes in IMPACT-III (r = -0.43 for anxiety, r = -0.45 for depressive symptoms, r = -0.43 for pain interference, r = -0.59 for fatigue, and r = 0.23 for peer relationships).
CONCLUSIONS: This study provides evidence for the longitudinal responsiveness of the PROMIS Pediatric measures to change in disease status and HRQOL in pediatric CD patients.
© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s; PROMIS; patient-reported outcomes (PROs); pediatric; responsiveness

Mesh:

Year:  2021        PMID: 32435792      PMCID: PMC7885314          DOI: 10.1093/ibd/izaa083

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  28 in total

1.  Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.

Authors:  Millie D Long; Michael D Kappelman; Christopher F Martin; James D Lewis; Lloyd Mayer; Patricia M Kinneer; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2012-01-27       Impact factor: 5.325

2.  The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease.

Authors:  Slaven Abdovic; Ana Mocic Pavic; Milan Milosevic; Mladen Persic; Irena Senecic-Cala; Sanja Kolacek
Journal:  J Crohns Colitis       Date:  2013-01-18       Impact factor: 9.071

3.  Patient-Reported Outcomes Measurement Information System Tools for Collecting Patient-Reported Outcomes in Children With Juvenile Arthritis.

Authors:  Timothy G Brandon; Brandon D Becker; Katherine B Bevans; Pamela F Weiss
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

4.  PROMIS pediatric measures in pediatric oncology: valid and clinically feasible indicators of patient-reported outcomes.

Authors:  Pamela S Hinds; Suzanne L Nuss; Kathleen S Ruccione; Janice S Withycombe; Shana Jacobs; Holly DeLuca; Charisse Faulkner; Yang Liu; Yao I Cheng; Heather E Gross; Jichuan Wang; Darren A DeWalt
Journal:  Pediatr Blood Cancer       Date:  2012-07-24       Impact factor: 3.167

Review 5.  Validation of Patient-Reported Outcomes for Clinical Trials in Allergic Rhinitis: A Systematic Review.

Authors:  Moises A Calderón; Thomas B Casale; Pascal Demoly
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-20

6.  PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.

Authors:  Darren A DeWalt; Heather E Gross; Debbie S Gipson; David T Selewski; Esi Morgan DeWitt; Carlton D Dampier; Pamela S Hinds; I-Chan Huang; David Thissen; James W Varni
Journal:  Qual Life Res       Date:  2015-02-26       Impact factor: 4.147

7.  Responsiveness to Change in PROMIS(®) Measures among Children with Asthma: A Report from the PROMIS(®) Pediatric Asthma Study.

Authors:  Carrie R Howell; Lindsay A Thompson; Heather E Gross; Bryce B Reeve; Darren A DeWalt; I-Chan Huang
Journal:  Value Health       Date:  2016-02-16       Impact factor: 5.725

8.  Assessing responsiveness over time of the PROMIS® pediatric symptom and function measures in cancer, nephrotic syndrome, and sickle cell disease.

Authors:  Bryce B Reeve; Lloyd J Edwards; Byron C Jaeger; Pamela S Hinds; Carlton Dampier; Debbie S Gipson; David T Selewski; Jonathan P Troost; David Thissen; Vaughn Barry; Heather E Gross; Darren A DeWalt
Journal:  Qual Life Res       Date:  2017-09-07       Impact factor: 4.147

9.  Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United States.

Authors:  Stacy A Kahn; Chia-Wei Lin; Burak Ozbay; Anthony Wang; Jingdong Chao; Martha Skup
Journal:  Inflamm Bowel Dis       Date:  2017-12       Impact factor: 5.325

10.  Promising insights into the health related quality of life for children with severe obesity.

Authors:  David T Selewski; David N Collier; Jackie MacHardy; Heather E Gross; Edward M Pickens; Alan W Cooper; Selam Bullock; Marian F Earls; Keeley J Pratt; Kelli Scanlon; Jonathan D McNeill; Kassandra L Messer; Yee Lu; David Thissen; Darren A DeWalt; Debbie S Gipson
Journal:  Health Qual Life Outcomes       Date:  2013-03-01       Impact factor: 3.186

View more
  5 in total

1.  Use of Patient-Reported Outcomes Measurement Information System Pediatric Measures as Clinical Trial Endpoints: Experience from a Multicenter Pragmatic Trial in Children with Crohn's Disease.

Authors:  Talya L Miller; Julia Schuchard; Adam C Carle; Christopher B Forrest; Michael D Kappelman
Journal:  J Pediatr       Date:  2021-11-03       Impact factor: 4.406

2.  Self-Reported Health Outcomes of Children and Youth with 10 Chronic Diseases.

Authors:  Christopher B Forrest; Julia Schuchard; Cortney Bruno; Sandra Amaral; Elizabeth D Cox; Kathryn E Flynn; Pamela S Hinds; I-Chan Huang; Michael D Kappelman; Jerry A Krishnan; Rajesh B Kumar; Jin-Shei Lai; Amy S Paller; Wanda Phipatanakul; Laura E Schanberg; Kaharu Sumino; Elissa R Weitzman; Bryce B Reeve
Journal:  J Pediatr       Date:  2022-03-02       Impact factor: 6.314

3.  Can Steps per Day Reflect Symptoms in Children and Adolescents Undergoing Cancer Treatment?

Authors:  Janice S Withycombe; Molly McFatrich; Pamela S Hinds; Antonia Bennett; Li Lin; Scott H Maurer; Nicole R Lucas; Courtney M Mann; Sharon M Castellino; Justin N Baker; Bryce B Reeve
Journal:  Cancer Nurs       Date:  2022-02-05       Impact factor: 2.760

4.  Validity and Responsiveness of the Patient-reported Outcomes Measurement Information System in Children With Ulcerative Colitis.

Authors:  Erica J Brenner; Millie D Long; Courtney M Mann; Li Lin; Wenli Chen; Camila Reyes; Kirsten M Bahnson; Bryce B Reeve; Michael D Kappelman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-07-01       Impact factor: 3.288

5.  Anxiety and Depressive Symptoms Are Not Associated With Future Pediatric Crohn's Disease Activity.

Authors:  Erica J Brenner; Millie D Long; Courtney M Mann; Li Lin; Wenli Chen; Camila Reyes; Kirsten M Bahnson; Bryce B Reeve; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2022-05-04       Impact factor: 7.290

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.